Table 2 Clinicopathological characteristics of the patients included in the study
Variable | Value (%) |
|---|---|
No. of patients | 58 |
Gender | |
Female | 13 (22.4%) |
Male | 45 (77.6%) |
Patient age (years) | |
≤ 60 | 21 (36.2%) |
> 60 | 37 (63.8%) |
Pathologic T stage | |
T1/T2 | 29 (50.0%) |
T3/T4 | 29 (50.0%) |
Pathologic N stage | |
Positive | 11 (19.0%) |
Negative | 47 (81.0%) |
Lymphangiosis carcinomatosa | |
Positive | 17 (29.3%) |
Negative | 41 (70.7%) |
Angioinvasion | |
Positive | 30 (51.7%) |
Negative | 28 (48.3%) |
Multiple tumour nodules | |
With | 13 (22.4%) |
Without | 45 (77.6%) |
Tumor size (mm) | |
≤ 50 | 11 (19.0%) |
> 50 | 47 (81.0%) |
Pathologic R category | |
R0 | 49 (84.5%) |
R1/R2 | 9 (15.5%) |
Histologic differentiation | |
Well | 11 (19.0%) |
Moderate/poor | 47 (81.0%) |
Distant metastases | |
With | 11 (19.0%) |
Without | 47 (81.0%) |
Tumor recurrence | |
With | 23 (39.7%) |
Without | 35 (60.3%) |
Local recurrence | |
With | 17 (29.3%) |
Without | 41 (70.7%) |